# Meridian Bioscience, Inc. clinical trials: 27 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with Meridian Bioscience, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Meridian Bioscience, Inc.: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/meridian-bioscience-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 12, 2023 | NCT05681156 | Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol | Meridian Bioscience, Inc. | Observational | Completed | Streptococcus Pneumoniae Infection, Legionella Pneumophila Serogroup 1 Infection | 199 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05681156) |
| September 21, 2018 | NCT03680898 | Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab... | Meridian Bioscience, Inc. | Not applicable | Unknown | Carbapenem-Resistant Enterobacteriaceae | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03680898) |
| August 2, 2018 | NCT03611101 | Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials | Meridian Bioscience, Inc. | Not applicable | Completed | NASH - Nonalcoholic Steatohepatitis | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03611101) |
| March 12, 2018 | NCT03462576 | Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17 | Meridian Bioscience, Inc. | Not applicable | Terminated | Decompensated Cirrhosis | 199 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03462576) |
| February 20, 2018 | NCT03439189 | Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14 | Meridian Bioscience, Inc. | Not applicable | Completed | NASH - Nonalcoholic Steatohepatitis, Cirrhosis, Portal Hypertension | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03439189) |
| February 5, 2018 | NCT03422341 | Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs. | Meridian Bioscience, Inc. | Not applicable | Completed | Pharyngitis, Infective | 497 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03422341) |
| August 16, 2017 | NCT03251261 | Detection of Cytomegalovirus Virus in Neonates | Meridian Bioscience, Inc. | Observational | Completed | CMV | 1,615 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03251261) |
| November 21, 2016 | NCT02968758 | Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains | Meridian Bioscience, Inc. | Not applicable | Completed | Clostridium Difficile Infection | 2,461 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02968758) |
| September 19, 2016 | NCT02905825 | Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics | Meridian Bioscience, Inc. | Phase 3 | Completed | Helicobacter Pylori Infection | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02905825) |
| June 9, 2016 | NCT02794805 | Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis | Meridian Bioscience, Inc. | Phase 2 | Completed | Hepatocellular Carcinoma (HCC) | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02794805) |
| March 24, 2016 | NCT02718157 | Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains | Meridian Bioscience, Inc. | Not applicable | Completed | Streptococcus Agalactiae Infection | 771 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02718157) |
| August 19, 2015 | NCT02528721 | Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection | Meridian Bioscience, Inc. | Phase 3 | Completed | Helicobacter Pylori Infection | 282 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02528721) |
| July 30, 2015 | NCT02511262 | Detection of Mycoplasma Pneumoniae | Meridian Bioscience, Inc. | Observational | Completed | Mycoplasma Pneumoniae | 471 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02511262) |
| December 10, 2014 | NCT02314026 | BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH | Meridian Bioscience, Inc. | Phase 2 | Completed | Non-Alcoholic Steatohepatitis | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02314026) |
| July 11, 2014 | NCT02187601 | Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function | Meridian Bioscience, Inc. | Not applicable | Completed | Chronic Liver Disease (CLD), Healthy Volunteers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02187601) |
| May 21, 2014 | NCT02143778 | Assessing Portal Hypertension With Methacetin Breath Test | Meridian Bioscience, Inc. | Not applicable | Completed | Patients With Compensated Liver Cirrhosis | 246 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02143778) |
| March 11, 2014 | NCT02084160 | Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation | Meridian Bioscience, Inc. | Observational | Completed | Chronic Liver Disease | 579 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02084160) |
| February 5, 2014 | NCT02055742 | Detection of Chlamydia (CT) and Gonorrhea (NG) | Meridian Bioscience, Inc. | Observational | Completed | Chlamydia, Gonorrhea | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02055742) |
| December 12, 2013 | NCT02010112 | Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori | Meridian Bioscience, Inc. | Phase 3 | Completed | Helicobacter Pylori Infection | 193 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02010112) |
| May 10, 2013 | NCT01851252 | MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy | Meridian Bioscience, Inc. | Phase 1 | Completed | Chronic Liver Disease, Cirrhosis, Esophageal Varices, Portal Hypertension, Bleeding | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01851252) |
| July 26, 2012 | NCT01650831 | Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection | Meridian Bioscience, Inc. | Not applicable | Completed | Suspicion of Being Infected With H.Pylori | 113 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01650831) |
| September 13, 2011 | NCT01433016 | Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI | Meridian Bioscience, Inc. | Phase 2 | Terminated | Chronic Liver Disease, Hepatocellular Carcinoma (HCC) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01433016) |
| December 14, 2010 | NCT01259544 | BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency | Meridian Bioscience, Inc. | Phase 2 | Completed | Chronic Pancreatitis, Healthy Volunteers | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01259544) |
| January 21, 2009 | NCT00825630 | 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors) | Meridian Bioscience, Inc. | Phase 4 | Completed | Helicobacter Pylori Infection | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00825630) |
| August 18, 2008 | NCT00736840 | BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis | Meridian Bioscience, Inc. | Phase 3 | Completed | Chronic Liver Disease | 414 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00736840) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 4 |
| Phase 4 | 1 |
| Not applicable | 10 |
| Observational | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Terminated | 4 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Fibrosis | 4 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Carcinoma, Hepatocellular | 3 |
| Hypertension, Portal | 2 |
| Hepatitis C | 2 |
| Chlamydia Infections | 1 |
| Gonorrhea | 1 |
| Streptococcal Infections | 1 |
| Pharyngitis | 1 |
| Pneumococcal Infections | 1 |
| Clostridium Infections | 1 |
| Pancreatitis, Chronic | 1 |
| Communicable Diseases | 1 |
| Infections | 1 |
| Esophageal and Gastric Varices | 1 |
| Hemorrhage | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Russian restaurants in the United States](https://specstream.ai/data/businesses/russian-restaurants/united-states)
- [Doner kebab restaurants in the United States](https://specstream.ai/data/businesses/doner-kebab-restaurants/united-states)
- [Recycling centers in the United States](https://specstream.ai/data/businesses/recycling-centers/united-states)
- [Dental laboratories in the United States](https://specstream.ai/data/businesses/dental-laboratories/united-states)
- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
